U.S. Tobacco Stock News

NYSE:TRGP
NYSE:TRGPOil and Gas

How Targa Resources’ Q2 2026 Earnings Surge and Modest Buybacks Could Impact Targa (TRGP) Investors

Targa Resources Corp. recently reported past second-quarter 2026 results, with revenue rising to US$4,440.1 million and net income reaching US$764.6 million, alongside higher basic earnings per share from continuing operations of US$3.54. Despite slightly lower year-to-date revenue than a year earlier, the company delivered sharply higher six-month net income of US$1,244.2 million and earnings per share, while its previously announced share repurchase programs saw only modest recent...
NYSE:GLP
NYSE:GLPOil and Gas

Global Partners (GLP) Stock Jumps As Cash Coverage Strengthens##

Global Partners came into this print with a solid recent run and a stock at about $50 that already reflected some optimism. The 3.4% pop after earnings indicates that investors liked what they saw. The headline is simple: profitability in this fuel and convenience network looks much stronger, with Q2 net income of $71.0 million and adjusted earnings before interest, tax, depreciation and amortization of $148.2 million. For income-focused holders, the raised quarterly cash distribution to...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Is Streaming Strength Amid Weaker Earnings Altering The Investment Case For Warner Bros. Discovery (WBD)?

Warner Bros. Discovery reported past second-quarter 2026 results showing revenue slipping to US$8,717 million from US$9,812 million a year earlier, while quarterly net income fell to US$149 million and the first half swung to a US$2.77 billion net loss from a US$1.13 billion profit. Behind these weaker headline numbers, the company’s streaming arm surpassed US$3 billion in quarterly revenue, helped by the Max–Disney+–Hulu bundle that reduced churn, even as management continued to back the...
NasdaqGS:CLMT
NasdaqGS:CLMTOil and Gas

Calumet (CLMT) Stock Falls As Cash Flow Strength Meets Equity Risk

Calumet stock dropped 5.7% to close at US$39.48 after its latest earnings, even though the quarter featured one clear headline. The company produced US$175m of adjusted earnings before interest, tax, depreciation and amortization, and generated more than US$90m of cash from operations, while continuing to pay down debt. In the short term, traders are reacting to a red price screen. Over a multi year horizon, the real story is the balance sheet repair. Management is retiring higher cost...
NYSE:AD
NYSE:ADWireless Telecom

Array Digital Infrastructure (AD) Stock Stalls Despite Tower And Spectrum Progress

Array Digital Infrastructure came into this earnings release with a bruised share price and a value label. The stock has fallen about 33% over the past three months, yet still trades on a trailing P/E of 4.6x compared with much richer wireless tower peers. Then Q2 landed with a jolt. Basic earnings per share jumped to US$3.86 and net income from ongoing operations reached US$333.77 million. The market barely flinched, with the stock slipping 1.1% to US$35.24 after the report. That muted move...
NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCB) Appoints Carl S Carande To Board And Risk Committee

United Community Banks (NYSE:UCB) appointed Carl S. Carande to its Board of Directors and Risk Committee. Carande is a former KPMG International Head of Global Advisory with roughly four decades of financial services and consulting experience. The appointment adds expertise in global risk, technology, and organizational strategy to United Community Banks' governance structure. For more context on where United Community Banks fits within the sector, consider exploring other bank and...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

Star Bulk Carriers (SBLK) Stock Looks Below Fair Value By 40%

Star Bulk Carriers has delivered a 151.7% total return over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the stock trading at a discount of around 40.1% to fair value. That mix of strong long term performance and ongoing valuation gap is drawing fresh attention after the latest earnings update and fleet expansion plans. Over five years the stock is up 151.7%, which means long term holders have already seen...
NYSE:FLR
NYSE:FLRConstruction

Fluor (FLR) Stock Jumps As Backlog Builds But Losses Linger

Fluor stock just put in a 16.9% one day jump, and that kind of move demands a sanity check. The headline is not a one off accounting quirk. Investors are reacting to a construction and engineering giant that delivered Q2 revenue of US$4.3b and adjusted earnings per share of US$0.91, while locking in US$6.1b of new awards and pushing backlog toward US$27b. The real story is whether this surge reflects a clean reset of sentiment on Fluor’s order book and earnings power, or if buyers are...
NasdaqGS:BL
NasdaqGS:BLSoftware

BlackLine (BL) Stock Looks Fairly Priced After a 74% Slump

BlackLine's share price has fallen sharply over the past five years, yet the valuation checks now suggest the stock is closer to fairly priced than a clear bargain or an obvious excess. BlackLine has declined 73.6% over the past five years, which puts a lot of past optimism into question and makes the current price more about what happens next than what has happened so far. The recent launch of Verity Prepare AI can support the case for better long term economics if adoption is strong, while...
NYSE:GPOR
NYSE:GPOROil and Gas

Gulfport Energy (GPOR) Posts Softer Results And CFO Exit, Where Does Fair Value Sit Now?

Why Gulfport Energy’s latest quarter is drawing attention Gulfport Energy (GPOR) has moved into focus after second quarter results showed lower quarterly revenue, net income, and production, alongside fresh full year production guidance and the upcoming resignation of its Chief Financial Officer. For you as an investor, this cluster of updates raises several questions. The mix of softer quarterly metrics, leadership change at the finance helm, and new production targets can influence how you...
NasdaqGS:TCOM
NasdaqGS:TCOMHospitality

Trip.com Group (TCOM) Stock Could Be Undervalued On China Hotel Rules

Trip.com Group stock has delivered an 86.1% gain over the past 5 years, yet the broader valuation checks still suggest the shares lean cheap. Recent share price weakness in 2026 leaves investors weighing that longer term return against a high value score and mixed shorter term performance. Over 5 years, Trip.com Group is up 86.1%, which points to meaningful value creation for longer term holders despite recent setbacks. The 2025 Sustainability Report and the new US$100 million Tourism...
NYSE:DOUG
NYSE:DOUGReal Estate

Douglas Elliman (DOUG) Stock Slips As Losses Ease But Risks Linger

Douglas Elliman slipped 0.6% to US$1.78 after its second quarter report, a muted move for a stock tied to luxury housing sentiment. The headline is not the price; it is the sharp improvement in the income statement. Revenue was US$283.4m and the quarterly loss narrowed to US$2.7m. For a brokerage that only recently turned profitable on a trailing basis, that combination turns today’s dip into a sentiment check rather than a clear verdict. The rest of the report shows how fragile or durable...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Should Upbound Group’s (UPBD) Refined 2026 Revenue Guidance Prompt Portfolio Moves From Investors?

In the second quarter of 2026, Upbound Group, Inc. reported sales of US$903.7 million, revenue of US$1.16 billion, and net income of US$21.58 million, with basic earnings per share from continuing operations of US$0.37, all modestly higher than a year earlier. The company also narrowed its full-year 2026 consolidated revenue outlook to US$4.70–US$4.85 billion and issued third-quarter revenue guidance of US$1.05–US$1.15 billion, giving investors a clearer view of expected scale and earnings...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Healthcare Stocks Investors Are Watching For Steady Demand After Weak US Jobs Data

A surprise loss of 23,000 US jobs in July and softer wage growth has put resilience back in the spotlight. Healthcare giants in areas such as pharmaceuticals and medical equipment are often watched closely when the broader economy looks less certain, because demand for many treatments can remain steady. This article reveals 3 large healthcare stocks from our screener that appear well placed against this backdrop. The three stocks highlighted below are just a sample from this theme, with the...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

GRAIL (GRAL) Could Be 5% Overvalued As FDA Review Date Sharpens Focus

Regulatory milestone puts focus on GRAIL stock GRAIL (GRAL) is in the spotlight after the FDA scheduled a September 23, 2026 advisory committee meeting to review the Premarket Approval application for its Galleri multi cancer early detection blood test. See our latest analysis for GRAIL. The FDA panel date has come alongside GRAIL’s recent Q2 update and a sharp 1 day share price return of 9.59%, even though the year to date share price return is down 21.82%. Over the past year, the total...
NYSE:BH.A
NYSE:BH.AHospitality

Biglari Holdings (BH.A) Stock Profit Rebound Meets Fading Earnings Momentum

Biglari Holdings stock barely flinched after earnings, easing just 0.3%, yet the headline result was anything but quiet. A swing to basic earnings per share of US$158.17 for the quarter, alongside net income of US$39.93 million, marks a sharp break from the recent run of losses. The market still treats Biglari as an unprofitable story with stretched valuation, which sets up a sentiment clash between the trailing weakness and a powerful single quarter of profitability. Is Biglari Holdings now...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Did Align’s Expanded 2026 Buyback and Board Refresh Just Shift Align Technology's (ALGN) Investment Narrative?

In late July 2026, Align Technology reported second-quarter 2026 results showing sales rising to US$1,056.19 million year-on-year, issued softer sequential revenue guidance for the third quarter, and outlined the impact of one-time restructuring, depreciation, and legal charges on its GAAP operating margin outlook. At the same time, after discussions with Elliott Investment Management, Align committed to appoint three new independent directors, launched a comprehensive strategic and...
NYSE:NFG
NYSE:NFGGas Utilities

3 US Large Cap Value Stocks Facing A Tougher Risk Test

With the Iran war disrupting the Strait of Hormuz, inflation staying stubbornly high and rate hikes still on the table, many investors are questioning how much risk is really baked into today’s lofty valuations. Periods like this can punish fragile business models but also reveal sturdier ones. This article focuses on 3 large cap value stocks that screens suggest are more exposed to these shocks, and explains what that could mean for your portfolio decisions. The three stocks below are only a...
NYSE:FIGS
NYSE:FIGSLuxury

FIGS (FIGS) Stock Looks Fully Valued Despite Raised 2026 Outlook

FIGS stock has delivered a very strong 129.3% return over the past year, yet its valuation checks still suggest the shares are not an obvious bargain. Recent optimism around growth and profitability now sits alongside a low overall value score and an assessment that the stock screens as overvalued on market multiples. The 129.3% one year return signals that expectations around FIGS have shifted quickly and that recent buyers are paying a much higher price than they were a year ago. Stronger...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors?

In the second quarter of 2026, Biogen Inc. reported revenue of US$2,736.0 million, up from US$2,645.5 million a year earlier, while net income fell to US$97.5 million and diluted earnings per share from continuing operations declined to US$0.66 from US$4.33. Despite higher sales and revenue, Biogen’s earnings compressed significantly, even as its newer therapies outpaced its legacy multiple sclerosis portfolio and the Apellis acquisition expanded its growth product lineup. We’ll now examine...
NYSE:VOYA
NYSE:VOYADiversified Financial

Voya Financial (VOYA) Faces Activist Pressure After Rally But Is It Fully Valued

TOMS Capital’s no confidence campaign against Voya Financial (VOYA) has moved into a new phase, with a definitive proxy filing and an open letter challenging the board’s decisions, recent execution, and approach to potential third party interest. See our latest analysis for Voya Financial. At a share price of US$101.40, Voya Financial has delivered a 26.54% 90 day share price return and a 46.36% 1 year total shareholder return. This suggests recent momentum has been strong despite the fresh...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton (DHI) Stock Looks Reasonable On Earnings While Cash Flow Stays Strong

D.R. Horton stock has delivered a 62.8% gain over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples currently point to the shares trading below what those frameworks suggest as fair. Over the last five years, D.R. Horton has returned 62.8%, which means long term holders have already seen solid value creation even before considering today’s valuation signals. Market expectations for future housing demand and construction activity can...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

ANI Pharmaceuticals (ANIP) Stock Slides As Cortrophin Concentration Clouds Profit Quality

ANI Pharmaceuticals just took a 5.3% hit in a single session, yet the earnings story looks more like growing pains than a broken thesis. You have a stock that came into the print soft over the past month, then sold off again right after reporting adjusted earnings per share of US$2.21 on revenue of US$266.0m. The real swing factor is profit quality. Investors appear to be wrestling with how much of the recent profitability and trailing US$259.6m of adjusted EBITDA reflects repeatable rare...
NasdaqGS:EMBC
NasdaqGS:EMBCMedical Equipment

Embecta (EMBC) Stock Jumps On Profit Rebound Despite Lingering Debt Strain

Embecta entered this quarter wearing the label of a deeply discounted diabetes device stock, with a single digit P/E and significant balance sheet questions. The market lifted the share price 26% to US$4.42 in the first session after earnings. The move reflects one headline takeaway: the business reported a sharp rebound in both revenue and profit, with Q3 sales of US$271.7m and net income of US$21.1m after a loss in Q2. For a company under pressure over debt and cash generation, that...